← FDA Drug Approvals (Drugs@FDA)
TOPIRAMATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2021-02-01
Drug application
- FDA Application #
ANDA210278- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TOPIRAMATE
- Generic name
- TOPIRAMATE
- Active ingredients
- TOPIRAMATE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLENMARK PHARMS LTD
- Manufacturer
- NorthStar RxLLC
- First approval
- 2021-02-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown